title: Management of glucocorticoid-induced osteoporosis: lessons for clinical practice.
authors.forename: Christian
authors.initials: C
authors.lastname: Roux
authors.forename: Gérald
authors.initials: G
authors.lastname: Rajzbaum
authors.forename: Gauthier
authors.initials: G
authors.lastname: Morel
authors.forename: Erick
authors.initials: E
authors.lastname: Legrand
authors.forename: Michel
authors.initials: M
authors.lastname: Laroche
authors.forename: Emmanuel
authors.initials: E
authors.lastname: Hoppé
authors.forename: Florence
authors.initials: F
authors.lastname: Chopin
authors.forename: Séverine
authors.initials: S
authors.lastname: Borg
authors.forename: Emmanuel
authors.initials: E
authors.lastname: Biver
authors.forename: Bernard
authors.initials: B
authors.lastname: Cortet
authors.forename: Thierry
authors.initials: T
authors.lastname: Thomas
mesh_terms: D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D050071:Bone Density Conservation Agents / Q000627:therapeutic use; D001862:Bone Resorption / Q000139:chemically induced / Q000517:prevention & control; D001842:Bone and Bones / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D005104:Expert Testimony; D005260:Female; D005598:Fractures, Spontaneous / Q000517:prevention & control; D005938:Glucocorticoids / Q000009:adverse effects*; D006801:Humans; D008297:Male; D010024:Osteoporosis / Q000139:chemically induced* / Q000517:prevention & control*; D058866:Osteoporotic Fractures / Q000517:prevention & control; D018579:Patient Selection
chemical_list: D000893:Anti-Inflammatory Agents; D050071:Bone Density Conservation Agents; D005938:Glucocorticoids